First Trust Capital Management’s Ra Pharmaceuticals, Inc. Common Stock RARX Stock Holding History

First Trust Capital Management’s Portfolio RARX Stock Details RARX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q2	–	Sell	-446	Closed	-$21K	–	83
2020 Q1	$21K	Buy	+446	New	+$20.7K	0.01%	26

Other funds holding RARX

Daiwa Securities Group Tokyo, Japan $34.8B AUM 20.7% 1-Year Est. Return

First Trust Capital Management's RARX Position: Q2 2020 in Review

First Trust Capital Management sold out of Ra Pharmaceuticals, Inc. Common Stock (RARX) in Q2 2020, closing a stake of 446 shares — an estimated $21K sold.

First Trust Capital Management first reported a position in RARX in Q1 2020 and held it in 1 quarter. The position peaked at $21K in Q1 2020. 1 fund tracked by Wall St. Rank holds RARX as of Q2 2020.

First Trust Capital Management reported no remaining Ra Pharmaceuticals, Inc. Common Stock position as of Q2 2020 after selling out during the quarter.
First Trust Capital Management sold 446 Ra Pharmaceuticals, Inc. Common Stock shares in Q2 2020, an estimated $21K.
First Trust Capital Management first reported a position in Ra Pharmaceuticals, Inc. Common Stock in Q1 2020 and held it in 1 quarter.
First Trust Capital Management's Ra Pharmaceuticals, Inc. Common Stock position peaked at $21K in Q1 2020.
1 fund tracked by Wall St. Rank held Ra Pharmaceuticals, Inc. Common Stock as of Q2 2020.

Based on First Trust Capital Management's 13F filing for Q2 2020, filed 13 Aug 2020.